...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

I realize that there are many possibilities and further thinking also makes me wonder if this is just teaming up with a Chinese partner as it is tough to deal in China without a Chinese partner. That doesn't change that one of our members posted a year ago that he had been told there was a sale coming and I have received from totally other sources that something similar was coming and should have happened by now but hasn't and probably isn't close. I hope I am wrong but I have been here long enough to have witnessed this many times now.

Share
New Message
Please login to post a reply